Entering text into the input field will update the search result below

Moderna to seek Japanese approval for COVID-19 vaccine later this week

Mar. 02, 2021 7:10 AM ETModerna, Inc. (MRNA) Stock, TAK StockTAK, MRNABy: Dulan Lokuwithana, SA News Editor5 Comments
  • Moderna (NASDAQ:MRNA) is planning to file for the approval of the Japanese health ministry’s approval for its COVID-19 vaccine as early as Friday, Kyodo News has reported.
  • The filing with Takeda Pharmaceutical (NYSE:TAK), the company’s partner in Japan for handling regulatory

Recommended For You

Related Stocks

SymbolLast Price% Chg
TAK
--
MRNA
--